DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Finks SW, Rogers KC.
Idarucizumab (Praxbind): The first reversal agent for a direct oral anticoagulant.
Am J Med 2017;
130: e195-e197
doi:10.1016/j.amjmed.2016.11.029
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.